The UK Medicines & Healthcare Products Regulatory Agency (MHRA) has published a consultation for industry comment regarding a proposed increase in fees the agency charges to run programs that serve patients, the public and industry. The aim of the consultation is to seek the views of stakeholders on proposals for changes to the agency’s statutory fees. The consultation closes at 11:45 p.m. on November 23, 2022. The fee increases are the largest that the agency has proposed in years. The last rate review was in 2016…
